KING OF PRUSSIA, PA, Jan. 7 /CNW/ - MDS Pharma Services, a leading
provider of innovative drug discovery and development solutions, today
announced the appointment of Rudy Howard as Senior Vice-President and Chief
Mr. Howard has extensive experience as a senior financial executive in
the pharmaceutical and contract research organization (CRO) industry sectors,
including six years as CFO at Pharmaceutical Product Development, Inc. He
joins MDS Pharma Services from his private consulting practice where he
offered business and financial consulting services, including merger and
acquisition services, for clients across a variety of industries, including
pharmaceutical and biotechnology.
"We are delighted to add someone with Rudy's breadth and depth of skills
and expertise to our leadership team at MDS Pharma Services," said MDS Pharma
Services President David Spaight. "His impressive portfolio of financial,
business development and change management capabilities in the pharmaceutical
and contract research industries makes him an excellent choice to lead the MDS
Pharma Services finance organization at this time."
Before founding his consulting practice, Mr. Howard was CFO at
Peopleclick Inc., a human resources software-development company. Previously,
he was a Partner at PricewaterhouseCoopers, where his specialization included
financial services, high technology, pharmaceuticals and manufacturing. He
began his career in public accounting with Deloitte and Touche LLP.
About MDS Pharma Services
MDS Pharma Services is committed to delivering quality service on-time.
We offer a full spectrum of resources to meet the drug-discovery and
development needs of the pharmaceutical and biotechnology industries. With
numerous facilities strategically located around the world, we apply advanced
scientific and technological expertise throughout the drug discovery and
development process - from lead optimization, pre-IND research, early clinical
research (bioequivalence, phases I-IIa) and bioanalysis through to global
clinical development (phases IIb-IV), central lab and centralized cardiac
services. For more information, visit our website at www.mdsps.com.
MDS Pharma Services is a business unit of MDS Inc. (TSX: MDS; NYSE: MDZ),
a global life-sciences company that provides market-leading products and
services that our customers need for the development of drugs and diagnosis
and treatment of disease. We are a leading global provider of pharmaceutical
contract research, medical isotopes for molecular imaging, radiotherapeutics,
and analytical instruments. MDS has more than 5,000 highly skilled people in
29 countries. Find out more at www.mdsinc.com or by calling 1-888-MDS-7222, 24
hours a day.
For further information:
For further information: Media: Charlene McGrady, (610) 239-7900, ext.
231, email@example.com; Investors: Kim Lee, (416) 213-4721,